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Abstract-Using in situ hybridization histochemistry, corticotropin-releasing hormone gene expression 
is first detectable in the parvocellular portion of the rat paraventricular nucleus on the 17th fetal day. The 
prevalence of messenger RNA for corticotropin releasing hormone decreases perinatally, specifically 
between the 19th and 21st fetal days. By the 4th postnatal day, CRH gene expression is similar to that of 
the adult rat. Somatostatin messenger-RNA is detectable on the 14th fetal day in the periventricular 
nucieus. No perinatal hiatus in somatostatin gene expression is evident. 
Key words: mRNA, CRH, corticotropin releasing factor, somatostatin development. 
Corticotropin releasing hormone (CRH), synthesized in the hypothalamic paraventricular nucleus 
(PVN), mediates the release of adrenocorticotropic hormone (ACTH) and corticosteroids in 
response to stressful stimuli, as part of the brain-pituitary-adrenal axis.‘* During the perinatal 
period in the rat, i.e. the stress non-responsive period, little perturbation of hormonal levels occurs 
in response to noxious events.’ The relationship between the regulation of CRH gene expression 
during late fetal and perinatal periods, and the onset of the stress-non-responsive-period has not 
been elucidated. This study explores the ontogeny of CRH messenger ibonucleic acid (CRH- 
mRNA) in the rat diencephalon, in ~mpa~son to that of an unrelated neuropeptide, ~matostatin. 
EXPERIMENTAL PROCEDURES 
Tissue Preparation 
Time-pregnant Sprague-Dawley derived rats were obtained from Zivic-Miller (Zelienople, 
PA) at least two days prior to sacrifice. Rats were kept on a 12 hour light/dark cycle (lights on 
7 a.m.-7 p.m.), and given access to unlimited lab chow and water. Pregnancy was dated by the 
presence of a vaginal plug (day 0). Gestation in these rats lasts for 21 days. Fetal brains were 
obtained daily starting on the 14th fetal day, and on postnatal days 1,4,19 and 100. Brains were 
obtained between 8:30 and 9:30 a.m. Prenatally, pregnant rats were anesthetized with COz, 
fetuses were quickly dissected and heads were removed onto powdered dry ice. Postnatally, pups 
were decapitated, and brains removed onto dry ice. Brains were stored at -80°C. 
Brains were cut into 20 micron coronal slices in a cryostat (IEC, MA) and mounted on gelatin- 
coated slides. Brain regions were identified by established landmarks.2v’0 Sequential sections were 
cut from the anterior commissure/septum through the caudal hypothalamus. 
Hybridization histochemistry 
Prior to in situ hybridization (ISH), slices were brought to room temperature, air-dried and 
fixed for 20 minutes in fresh 4% buffered PBS-paraformaldehyde. Sections were dehydrated 
through increasing ethanol concentrations, rehydrated, exposed for 8 minutes to 0.5% acetic 
anhydride -0.1 M triethanolamine (pH = 8), then dehydrated through 100% ethanol. 
ISH was modified from Young et al. ,I3 as previously described.3 Briefly, prehybridization for 
one hour in hybridization buffer (0.2 ml/slice) was followed by a 20 hour ISH at 37°C. Hybridiza- 
tion buffer consisted of: 50% formamide, 4 x SSC (1 x SSC is 0.15 M NaCl in 0,015 M sodium 
citrate, pH = 7), 0.5 gm/ml sheared, single-stranded salmon sperm DNA, 25 mcg/ml yeast tRNA, 
tAuthor to whom correspondence should be addressed: Div. Neurology, CHLA, P.O. Box 54700, Los Angeles, CA, 
90054-0700, U.S.A. 
Abbreviation: ACTH, adrenocorticotropic hormone; CRH, corticotropin releasing hormone; ISH, in situ 
hybridization; mRNA, messenger ri~nucleic acid; PVN, paravent~cular nucleus; SCA. subcortical area. 
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100 mM DTT, 5 x Denhardt’s solution and 10% dextran sulfate. Reaction volume was 0.03 mli 
section, under a coverslip in a humidity chamber. ISH was followed by serial washes at 37°C‘: 
4 X 15 minutes in 2 X SSC, then 30 minutes each in 1 X and 0.4 x SSC. The last two washes were 
at room temperature. Hybridized slices were dehydrated and apposed to film (Hyperfilm B-max. 
Amersham, IL) for 24 hours and developed in 80% solution D-19 Kodak developer.# 
A 60 nucleotide synthetic probe corresponding to the codons for the 20 COOH-amino acids of 
CRH3,” was generated using an Applied Biosystems (Foster City, CA) DNA Synthesizer. After 
purification, the probe was labelled on the 3’ end with dATP-S3’ (NEN, Wilmington, DE) using 
terminal deoxynucleotidyl transferase’ (Bethesda Research Labs.). Specific activity of labelled 
probes was 5-8 x lo8 dpm/mcg. The complementary ‘sense’ strand and the 39 oligonucleotide 
probe for somatostatin-mRNA,’ were similarly generated and labelled. 
Quantitation and statistical analysis 
Serial sections of the PVN at each age were examined, and those with the maximal area of 
PVN, based on toluidine blue staining, were used for analysis. Films were mounted on a light 
table with a precision illuminator (Northern Light B90; Imaging Research, St. Catherine, 
Ontario, Canada). Images were acquired by a Sierra Scientific high resolution camera (Sunnyvale, 
CA), and optical density (OD) was determined using the MCID software image analysis system 
(Imaging Research, St. Catherine, Ontario, Canada). Optical density was determined over the 
paraventricular nucleus, as well as over the parietal cortex for CRH-mRNA assessment; OD over 
the latter was defined as background. For slices subjected to ISH for somatostatin-mRNA, OD 
was determined over the anterior, basal periventricular nucleus and over the subcortical area 
underlying the lateral ventricles of the same slice (SCA). Since even sections subjected simultan- 
eously to ISH, processed together and apposed to the same sheet of film had different background 
optical density, the ratios of OD of PVN and parietal cortex were used for comparison for CRH. 
For the same reason, the OD ratio of periventricular nucleus to SCA was utilized as a measure of 
the prevalence of somatostatin-mRNA. Five ratios, derived from at least 3 animals from two 
separate litters, were obtained for each age group, and means and standard deviations were 
determined for each age. Analysis of variance (Minitab, University Park, PA), was used to assess 
the significance of differences between age groups. Brainpaste standards13 were apposed to each 
film, to ascertain that all samples were in the linear range of OD/cpm. 
RESULTS 
Using in situ hybridization, CRH gene expression is not detectable in hypothalami of 16 day 
fetal rats. Sequential slices, spanning the region from the medial preoptic/anterior commissure 
caudally to the mammillary bodies are free of specific hybridization to CRH probe (Fig. 1). 
CRH-mRNA is present in 17 and 18 day fetal rat brain slices in a globoid, symmetric paraven- 
tricular region measuring 80 microns in diameter, bordering on the 3rd ventricle (Fig. 2). By the 
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Fig. 1. Ontogeny of CRH gene expression in rat paraventricular nucleus. Results are expressed as means 
and standard deviations of 5 samples. See text for details of semiquantitative analysis. F16, etc., denote 
fetal days; Pl, etc., denote postnatal days. AD = adult. Values of F21 and Pl are significantly (P<O.Ol) 
different than those of F19 and P4. 
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2. Photomicrograph of paraventricular nucleus of a 17-day-old fetal rat subjected to ISH with S3’- 
:Iled probe for CRH-mRNA. See Experimental Procedures for details of ISH. Bar x 1 mm. 
PVN = paraventricular nucleus. 




4. Coronal section of the diencephalon of a 17-day-old fetal rat subjected to ISH with a labelled 
,onucIeotide complementary to Somatostatin-mRNA. Bar x 1 mm. AH X Amygdalolhippocampal 
rplex, hpv = periventricular nucleus, LAT= lateral ventricle, DLT = dorsolateral thalamus, PFC = 
parietofrontal cortex 
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Fig. 3. Ontogeny of somatostatin-mRNA in the rat periventricular nucleus. Results are expressed as the 
means and standard deviations of 5 samples. F14, etc. denote fetal days; Pl is the first postnatal day. 
AD = adult. Value at F2I is not significantly different than those at F17 or PI 
19th fetal day, the CRH-mRNA containing portion of the PVN spans 140 microns in the rostro- 
caudal dimension, and has begun to assume the more triangular shape of the mature parvocellular 
PVN. CRH gene expression is robust during the 17-19th fetal days, but decreases by the last, 21st 
fetal day. As seen in Fig. 1, CRH-mRNA is relatively abundant again by the 4th postnatal day, 
when the ratio of optical densities of PVN and cortex is similar to adult values. 
Somatostatin gene expression is first evident in rat diencephalon on the 14th fetal day (Fig. 3). 
As evident from the figure, no perinatal reduction occurs in the prevalence of somatostatin- 
mRNA in the periventricular nucleus. Somatostatin-mRNA localization in the basal periventri- 
cular region (as well as in the hippocampo-amygdala complex and in circumsc~bed cortical areas) 
on the 17th fetal day, is shown in Fig. 4. 
DISCUSSION 
In this study, using adjacent sections of the same brains, we investigated the ontogeny of CRH 
and somatostatin gene expression in the rat diencephalon. Our findings of the appearance of ISH- 
detectable CRH-mRNA on the 17th fetal day is in agreement with those reported by Grino et al. ,’ 
who utilized ISH as well. Quite recently, Emanuel et al. ,4 employing northern blot analysis of 
total brain or hy~thalamic RNA, reported the presence of CRH-mRNA as early as the 15th fetal 
day. These investigators did not find any perinatal decrease in the amount of CRH-mRNA, as 
opposed to Grino’s results and those reported above. The basis for this discrepancy may well be 
the use of whole hypothalami: CRH-mRNA present in areas other than the PVN, (e.g., supra- 
optic or suprachiasmatic nuclei) may not fluctuate and may ‘dilute’ any changes een solely in the 
PVN. A review of Fig. 2 in Emanuel’s report4 suggests a marked decrease in CRH-mRNA pre- 
valence between the 15th fetal day and the subsequent samples obtained on the 20th and 21st 
fetal days. 
The perinatal decrease in CRH-mRNA seems to be relatively specific for this peptide, since no 
such transient decrease was observed for somatostatin-mRNA. These findings are in agreement 
with published observations.“4 These investigators, using northern blot analysis, found the onset 
of somatostatin gene expression on the 15th and 14th fetal day, respectively. Both authors 
reported a steady increase in somatostatin-mRNA prevalence in rat hypothalamus from the late 
fetal age onwards. 
In summary, we demonstrate the onset of CRH gene expression on the 17th fetal day in the rat 
PVN. CRH-mRNA prevalence decreases perinatally, then increases to adult values by the 4th 
postnatal day. Somatostatin-mRNA, present in rat diencephalon by the 14th fetal day, does not 
undergo a similar perturbation. 
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